Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Adenosine receptor A2b | ||
Ligand | BDBM561431 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Adenosine A2B Receptor Cyclic AMP GS Assay | ||
EC50 | <10±n/a nM | ||
Citation | Huang, T; Wang, X Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors US Patent US11390624 Publication Date 7/19/2022 | ||
More Info.: | Get all data from this article, Assay Method | ||
Adenosine receptor A2b | |||
Name: | Adenosine receptor A2b | ||
Synonyms: | AA2BR_HUMAN | ADENOSINE A2B | ADORA2B | Adenosine receptor A2B (A2B) | Adenosine receptors A2b | Adenosine receptors; A2a & A2b | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 36341.22 | ||
Organism: | Homo sapiens (Human) | ||
Description: | n/a | ||
Residue: | 332 | ||
Sequence: |
| ||
BDBM561431 | |||
n/a | |||
Name | BDBM561431 | ||
Synonyms: | 3-(4-amino-2-((1-methyl-1H-pyrazol-3-yl)methyl)-7-(4-methyloxazol-5-yl)-2H-[1,2,3]triazolo[4,5-c]pyridin-6-yl)benzonitrile | US11390624, Example 45 | ||
Type | Small organic molecule | ||
Emp. Form. | C21H17N9O | ||
Mol. Mass. | 411.4194 | ||
SMILES | Cc1ncoc1-c1c(nc(N)c2nn(Cc3ccn(C)n3)nc12)-c1cccc(c1)C#N |(2.08,2.32,;.61,2.8,;.13,4.26,;-1.41,4.26,;-1.88,2.8,;-.64,1.9,;-.64,.36,;-1.97,-.41,;-1.97,-1.95,;-.64,-2.72,;-.64,-4.26,;.7,-1.95,;2.16,-2.43,;3.07,-1.18,;4.61,-1.18,;5.38,.15,;4.75,1.56,;5.9,2.59,;7.23,1.82,;8.64,2.44,;6.91,.31,;2.16,.06,;.7,-.41,;-3.3,.36,;-3.3,1.9,;-4.64,2.67,;-5.97,1.9,;-5.97,.36,;-4.64,-.41,;-7.3,-.41,;-8.64,-1.18,)| | ||
Structure |